Logo
  • Technology
  • Products
  • Market
  • About us
  • News
    • Regulatory news
  • Investor relations
  • Svenska
martin

Redwood Pharma CEO Martin Vidaeus to present at BioStock Life Science Spring Summit

Redwood Pharma will participate at the BioStock Investor Meeting on June 8. 

The presentation starts at 12:40 pm CET.

Follow the event online here: https://www.youtube.com/watch?v=RmhNVEZSCww

#RedwoodPharma #BioStockSWE  #investormeeting #LifeSciences

2022-06-03



Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

  • Welcome
  • Technology
  • Products
  • Market
  • About us
  • News
    • Regulatory news
  • Investor relations
    • Reports
    • Presentations
  • Privacy Policy

Contact

Martin Vidaeus – CEO
070-232 29 29
martin.vidaeus@redwoodpharma.com

Ringvägen 100E, floor 9
118 60 Stockholm, Sweden

Logo

Nasdaq First North Growth Market: (REDW)
© 2023 Copyright Redwood Pharma.